These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15607266)

  • 1. Improved paracellular uptake by the combination of different types of permeation enhancers.
    Guggi D; Bernkop-Schnürch A
    Int J Pharm; 2005 Jan; 288(1):141-50. PubMed ID: 15607266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine.
    Werle M; Hoffer M
    J Control Release; 2006 Mar; 111(1-2):41-6. PubMed ID: 16377016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of various buccal permeation enhancing systems for PACAP (pituitary adenylate cyclase-activating polypeptide).
    Langoth N; Bernkop-Schnürch A; Kurka P
    Pharm Res; 2005 Dec; 22(12):2045-50. PubMed ID: 16132338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved synthesis of quaternary ammonium-chitosan conjugates (N+ -Ch) for enhanced intestinal drug permeation.
    Zambito Y; Zaino C; Uccello-Barretta G; Balzano F; Di Colo G
    Eur J Pharm Sci; 2008 Apr; 33(4-5):343-50. PubMed ID: 18296036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system.
    Hombach J; Hoyer H; Bernkop-Schnürch A
    Eur J Pharm Sci; 2008 Jan; 33(1):1-8. PubMed ID: 17980561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein.
    Föger F; Hoyer H; Kafedjiiski K; Thaurer M; Bernkop-Schnürch A
    Biomaterials; 2006 Dec; 27(34):5855-60. PubMed ID: 16919723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir.
    Palmberger TF; Hombach J; Bernkop-Schnürch A
    Int J Pharm; 2008 Feb; 348(1-2):54-60. PubMed ID: 17716840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of the intestinal membrane permeability of low molecular weight heparin by complexation with stem bromelain.
    Grabovac V; Bernkop-Schnürch A
    Int J Pharm; 2006 Dec; 326(1-2):153-9. PubMed ID: 16950580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan.
    Föger F; Schmitz T; Bernkop-Schnürch A
    Biomaterials; 2006 Aug; 27(23):4250-5. PubMed ID: 16618504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a mucoadhesive and permeation enhancing buccal delivery system for PACAP (pituitary adenylate cyclase-activating polypeptide).
    Langoth N; Kalbe J; Bernkop-Schnürch A
    Int J Pharm; 2005 May; 296(1-2):103-11. PubMed ID: 15885461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system.
    Bernkop-Schnürch A; Guggi D; Pinter Y
    J Control Release; 2004 Jan; 94(1):177-86. PubMed ID: 14684281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
    Krauland AH; Guggi D; Bernkop-Schnürch A
    J Control Release; 2004 Mar; 95(3):547-55. PubMed ID: 15023465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiolated chitosan: development and in vivo evaluation of an oral delivery system for leuprolide.
    Iqbal J; Shahnaz G; Perera G; Hintzen F; Sarti F; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2012 Jan; 80(1):95-102. PubMed ID: 21964316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of permeation enhancing strategies for an oral factor Xa inhibitor using the Caco-2 cell monolayer model.
    Bruesewitz C; Funke A; Kuhland U; Wagner T; Lipp R
    Eur J Pharm Biopharm; 2006 Oct; 64(2):229-37. PubMed ID: 16904877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems.
    Bernkop-Schnürch A; Kast CE; Guggi D
    J Control Release; 2003 Dec; 93(2):95-103. PubMed ID: 14636716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs.
    Rozehnal V; Nakai D; Hoepner U; Fischer T; Kamiyama E; Takahashi M; Yasuda S; Mueller J
    Eur J Pharm Sci; 2012 Aug; 46(5):367-73. PubMed ID: 22418036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological evaluation of buccal penetration enhancement properties of chitosan and trimethyl chitosan.
    Sandri G; Poggi P; Bonferoni MC; Rossi S; Ferrari F; Caramella C
    J Pharm Pharmacol; 2006 Oct; 58(10):1327-36. PubMed ID: 17034655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific permeability modulation of intestinal paracellular pathway by chitosan-poly(isobutylcyanoacrylate) core-shell nanoparticles.
    Bravo-Osuna I; Vauthier C; Chacun H; Ponchel G
    Eur J Pharm Biopharm; 2008 Jun; 69(2):436-44. PubMed ID: 18395430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of glutathione in the permeation enhancing effect of thiolated polymers.
    Clausen AE; Kast CE; Bernkop-Schnürch A
    Pharm Res; 2002 May; 19(5):602-8. PubMed ID: 12069161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiolated chitosans: influence of various sulfhydryl ligands on permeation-enhancing and P-gp inhibitory properties.
    Sakloetsakun D; Iqbal J; Millotti G; Vetter A; Bernkop-Schnürch A
    Drug Dev Ind Pharm; 2011 Jun; 37(6):648-55. PubMed ID: 21561400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.